Anaphylaxis Action Plans

Anaphylaxis Action Plans

After exposure to a triggering allergen, anaphylaxis can occur suddenly, with serious, sometimes fatal, results.1,2 Preparedness among susceptible patients is critical and includes the development and implementation of anaphylaxis action plans.1,3 An example of an action plan from the AAAAI is available for here. Generally, these plans include lists of anaphylactic symptoms, as well as emphasizing the importance of prompt treatment with an epinephrine auto-injector and seeking emergency medical attention.1 These plans should also include information specific to the individual, such as comorbidities, other medications, prescribed EpiPen dose and emergency contacts.1 Anaphylaxis action plans should be discussed and regularly updated with the patient or caregiver.1 It is also important that physicians discuss the plan with nurse practitioners, physician assistants and/or office staff so that they can reinforce the details of the plan with the patient and/or caregiver.1

To download a sample action plan from the American Academy of Allergy, Asthma & Immunology website, please click here.


EpiPen® (epinephrine) 0.3 mg and EpiPen Jr® (epinephrine) 0.15 mg Auto-Injectors are indicated in the emergency treatment of type 1 allergic reactions, including anaphylaxis, to allergens, idiopathic and exercise-induced anaphylaxis, and in patients with a history or increased risk of anaphylactic reactions. Selection of the appropriate dosage strength is determined according to body weight.

Important Safety Information

EpiPen Auto-Injectors should only be injected into the anterolateral aspect of the thigh. DO NOT INJECT INTO BUTTOCK, OR INTRAVENOUSLY.

Epinephrine should be used with caution in patients with certain heart diseases, and in patients who are on drugs that may sensitize the heart to arrhythmias, because it may precipitate or aggravate angina pectoris and produce ventricular arrhythmias. Arrhythmias, including fatal ventricular fibrillation, have been reported in patients with underlying cardiac disease or taking cardiac glycosides or diuretics. Patients with certain medical conditions or who take certain medications for allergies, depression, thyroid disorders, diabetes, and hypertension, may be at greater risk for adverse reactions. Other adverse reactions include transient moderate anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.

EpiPen and EpiPen Jr Auto-Injectors are intended for immediate self-administration as emergency supportive therapy only and are not intended as a substitute for immediate medical or hospital care.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

For additional information please contact us at 800-395-3376.